Income-Tax Dept searches 20 premises of Claris LifesciencesIncome-Tax sleuths today conducted search and survey operations at around 20 commercial and residential premises of Claris Lifesciences, it...
Carlyle Group sells its entire 11.29% stake in Claris LifesciencesCarlyle Group offloaded its entire 11.29 per cent stake in drug-maker Claris Lifesciences for a little over Rs 170 crore through an open ma...
Claris transfers two businesses to Japan JV for Rs 1,050 crClaris will continue to hold a 20 per cent stake in the JV, while Otsuka and Mitsui will hold 60 and 20 per cent in it, respectively, a com...
- Claris Lifesciences gets FIPB nod for Japanese JV, Q1 net down by 29%
Ahmedabad-based Claris Lifesciences registered de-growth of 29% in its first quarter ended on 31st March 2013.
- Claris promoter sells 12 lakh shares for over Rs 23 crore
Claris Lifesciences promoter Aditya Sushil Kumar Handa today offloaded nearly 12 lakh shares of the pharma company for over Rs 23 crore.
- Claris Lifesciences to invest Rs 900 crore on business growth, pre-payment of debt
Claris Lifesciences on Thursday said it will invest Rs 900 crore, which it expects to receive as part of divestment of 80 per cent stake in...
- Claris Lifesciences inks JV with Japanese drug maker Otsuka Pharma & Mitsui for Indian market
Ahmedabad-based Claris Lifesciences Limited, India executed agreements for a Joint Venture with two Japan-based drug makers Otsuka Pharmace...
- Claris Lifesciences Net Profit dips 27%, revenue down by 5%
Claris Lifesciences Ltd, net profit dips successive for second time in a year. The net profit for the third quarter dropped by 27.34% and r...
- Buy Claris Lifescience with a price target of Rs 280: Prakash Gaba
Buy Claris Lifescience with a price target of Rs 280 and a stop loss of Rs 240.
Mitsui in talks to invest Rs 250 crore in ClarisSources said the Japanese group's healthcare company might pick up stake from private equity players invested in Claris or invest in a join...
Pfizer ends supply deal with Claris LifesciencesMultinational drug-maker Pfizer Inc has terminated its three-year old supply deal with Claris Lifesciences, immediately after a ban on the ...
- Morgan Stanley, Barclays buy Claris bulk shares in open market on USFDA clearance
Claris said it has formally received the letter from USFDA stating that it has completed its evaluation of the firm's corrective actions.
- Claris Lifesciences net profit falls 14%, USFDA clearance awaiting
The consolidated net profit stood at Rs 32.32 crore for second quarter ended on 30 June 2012 compared to Rs 37.72 crore for the same period...
- Claris Lifesciences yet to get USFDA clearance
Claris Lifesciences said its consolidated net profit rose 9% for the first quarter of calendar year 2012 to Rs 21.7 crore.
- Citi offloads over 3 lakh shares of Claris Lifesciences
Foreign fund house Citigroup sold 3.19 lakh shares, worth about Rs 5 crore, of drug-maker Claris Lifesciences through an open market transa...
- Claris receives MHRA approval for Ahmedabad unit
Claris Lifesciences Limited today announced that it has received approval for its plant at Ahmedabad from the MHRA of the United Kingdom.
- Claris recalls three anti-biotic drugs from US
Ahmedabad-based drug-maker Claris Lifesciences on Monday recalled three antibiotic drugs from the US market following an alert issued by th...